Outcomes of Robotic Total Hip Arthroplasty

November 4, 2013 updated by: Charles R. Bragdon, Massachusetts General Hospital

Outcomes of Robotic Total Hip Arthroplasty: A Prospective Study

The objectives of this study are to evaluate the clinical value of robotic-assisted total hip arthroplasty with respect to acetabular cup implantation, and to document the long-term clinical outcome of patients with Total Hip Arthroplasty (THA). IRB approval will be obtained at every study site to evaluate the basic clinical outcomes and post-operative component placement accuracy of each MAKO® THA patient.

The hypothesis is that robotic preparation of the acetabulum will significantly reduce the variability and inaccuracy in the component alignment parameters that lead to post-operative complications, including implant failure.

Study Overview

Status

Withdrawn

Conditions

Study Type

Observational

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Massachusetts
      • Boston, Massachusetts, United States, 02114
        • Massachusetts General Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Adults requiring a total hip arthroplasty procedure.

Description

Inclusion Criteria:

  • Male or female
  • 20 to 75 years of age
  • Subjects requiring primary total hip replacement
  • Contralateral hip should be relatively free from arthritis for comparison purposes, specifically with less than a grade of 2 on the Kellgren-Lawrence Scale.
  • Subjects diagnosed with osteoarthritis or traumatic arthritis
  • Subjects with avascular necrosis
  • Subjects who demonstrate the ability to return for follow-up for the next 10 years

Exclusion Criteria:

  • Subjects with difficulty understanding protocol for any reason
  • Subjects with a limited life span
  • Subjects with inflammatory hip disease, previous joint infection, or those requiring hip revision surgery
  • Female subjects who are pregnant, or who plan to get pregnant while enrolled in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Phase II
An evaluation of long-term outcomes, patient reported outcomes, and radiographic analysis will be conducted prospectively on 500 patients
Phase I
An analysis of post-operative component positioning will be evaluated for 500 patients, retrospectively.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Survivorship of Components
Time Frame: 10 Years
Defined as implant remaining in subject.
10 Years
Adverse Events
Time Frame: 10 Years
Protocol deviations, complications, "lost to follow-up"
10 Years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Retrieval Analysis of implants from revision surgery
Time Frame: Up to 10 Years
When possible, analysis of the THR components that are removed at revision surgery will be anlaysed for signs of component impingment or signs of damage related to component position. These observations will be correlated to the clinical reason for revision.
Up to 10 Years

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assessment/questionaire HOOS
Time Frame: Pre-op, 1, 3, 5, 7, 10 years after surgery
Hip Disability and Osteoarthritis Outcome
Pre-op, 1, 3, 5, 7, 10 years after surgery
Assessment/Questionaire UCLA Activty Score
Time Frame: Pre-op, 1, 3, 5, 7, 10 years after surgery
Assesses level of activity
Pre-op, 1, 3, 5, 7, 10 years after surgery
Assessment/Questionaire EQ-5D
Time Frame: Pre-op, 1, 3, 5, 7, 10 years after surgery
General health and cost effective analysis
Pre-op, 1, 3, 5, 7, 10 years after surgery
Assessment/questionaire
Time Frame: Pre-op, 1, 3, 5, 7, 10 years after surgery
Hip desease specific questionaire
Pre-op, 1, 3, 5, 7, 10 years after surgery
Assessment/Questionaire Case Mix Indicator
Time Frame: Pre-op, 1, 3, 5, 7, 10 years after surgery
Identifies comorbidities
Pre-op, 1, 3, 5, 7, 10 years after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2013

Primary Completion (Anticipated)

January 1, 2023

Study Completion (Anticipated)

January 1, 2023

Study Registration Dates

First Submitted

August 10, 2012

First Submitted That Met QC Criteria

August 21, 2012

First Posted (Estimate)

August 24, 2012

Study Record Updates

Last Update Posted (Estimate)

November 5, 2013

Last Update Submitted That Met QC Criteria

November 4, 2013

Last Verified

November 1, 2013

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Osteoarthritis

Subscribe